ARRB2 and breast carcinoma: According to our TCGA analysis, despite a slight increase in the expression of βArr2 in tumour samples compared to normal samples, a significant downregulation was observed in molecular subtypes of breast cancers (Luminal A, Luminal B or Her2-enriched) compared to the Normal-like phenotype.